Blog

[Le French Gut] – Biofortis is part of the national project Le French Gut, to accelerate the science of the microbiota

Biofortis as a unique full service CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science for Human and Animal Health is part of Le French Gut project. Le French Gut project National contribution to collect 100,000 faecal samples and...

Biofortis continues its development alongside Institut Mérieux

Benoît Fouchaq, CEO of Biofortis SASAs part of a new strategy, Mérieux NutriSciences has decided to sell the majority of Biofortis’ shares to its Management, through a “Management Buy-Out” project. However, the Institut Mérieux, a major player in the service of public...

[PRESS RELEASE] Biofortis and ProDigest announce an agreement for a global collaboration in the field of Gastrointestinal Research

Ghent, Belgium and Saint-Herblain, France Oct. 23, 2020 – ProDigest, specialists in intestinal research and Biofortis, Mérieux NutriSciences’ Contract Research Organization serving innovation in nutrition, health, and microbiota studies, enter into a global...

Pharmabiotics 2020

Pharmabiotics 2020 March 10/11th Biofortis team will attend Pharmabiotics 2020 March 10-11th of March : focused on Microbiome Business, Sciences & Regulatory Affairs. During this event, Institut Merieux is pleased to deliver an award. The Pharmabiotics Young...

[EVENT] Biofortis, membre du comité d’organisation et Sponsor Silver de la Journée Nutrition & Microbiote 2025

16 octobre 2025, Nantes FRBiofortis participera à la Journée Nutrition & Microbiote, organisée par Atlanpôle Biothérapies, le 16 octobre 2025, en tant que membre du comité d’organisation, avec l’implication de Thomas Carton (Scientific Operations Manager), et...

[EVENT] – Biofortis and analyze & realize will be present at Vitafoods Europe 2025

May 20th/21st/22nd, 2025in Barcelona, SpainFor this 2025 edition, we will be present in the booth 3J136F on French Pavilion. Vitafoods Europe is one of the most important events in the world’s nutraceutical. Each year, the event gathers thousands of attendees and...

[ARTICLE] The intestinal microbiota, a major player in colorectal cancer

The colorectal cancer (CRC) ranks among the top 3 most frequent and deadly cancers in both men and women. Although the gut microbiota plays a pivotal role in maintaining intestinal homeostasis and overall health, recent research suggests its significant involvement in...

[PRESS RELEASE] Biofortis and Teranga strengthen their service offerings with the acquisition of NEOVIX group

A Strategic expansion to enhance services in Health & Wellness Nantes, France – March 4, 2025 – We are pleased to announce our strategic partnership with TERANGA Group. With the acquisition of NEOVIX Group (including AR2i, Cosmetic Office, White Tillet, SCM...

[WEBPAPER] Patient Reported Outcomes: how to develop it and why use it in clinical studies?

Feb 24, 2022 | Health

« On a scale of 1 to 10, how do you feel today? » This is one of the questions that many patients may be confronted...

[ARTICLE] – Trial registration: different tools, same ethical principle.

Jan 27, 2022 | Food, Health, Nutrition

As described by the World Health Organization (WHO), “the registration of all interventional trials is considered to...

Innovation Sponsor – MDD 2022

Jan 5, 2022 | News

6th Microbiome Movement Drug Development Europe 2022 January, 26th-27th Come and e-meet us at the 6th Microbiome...

Poster: Decrease diarrheal symptoms and modulation of intestinal microbiota by a new synbiotic in a murine model of food allergy

Dec 7, 2018 | Microbiome

This poster describes some of the microbiome analyses results obtained on a in vivo murine model of food allergy designed for the ProtAlSafe project. ...

Biobank in oncology: Biofortis & IMODI project

Nov 23, 2018 | Health

Biofortis has been a partner for 7 years in the IMODI project, a public-private consortium of 18 partners aiming at some developing experimental models for human cancers (liver, prostate, ovarian,...

Microbiome Hopes For Cancer Therapies

Nov 16, 2018 | Microbiome

DR SIDONIE N. LAVERGNE, COLLABORATIVE PARTNERSHIP MANAGER, BIOFORTIS MERIEUX NUTRISCIENCES Photo from Imactiv-3D (NOD-SCID MOUSE INTESTINE (10X) STAINED WITH PROPIDIUM IODIE AFTER BABB...

Interview with Pr Vassili Soumelis, MD-PhD, Hôpital Saint-Louis (Paris, France)

Nov 9, 2018 | Health

Pr Soumelis is a medical doctor specialized in hematology. He received his medical training in Paris, followed by a residency in clinical hematology in Lyon, and a PhD in immunology in the USA (DNAX...

Interview with OCR (Oncovet Clinical Research), Dr Dominique Tierny, DVM, CEO at OCR and Dr Agata Rybicka, DVM, PhD, Head of R&D at OCR

Nov 2, 2018 | Health

OCR is a veterinary Contract Research Organization specialized in the design and monitoring of clinical trials on companion dogs and cats that spontaneously develop various chronic diseases like...

Interview with Dr Béatrice Perron, Oncology Portfolio Management Director at Servier

Oct 26, 2018 | Health

Dr Perron holds a MSc Engineering and a PhD in biotechnology from Ecole Centrale Paris. She joined Servier in November 2015 as Strategy and Portfolio Director in the Center for Therapeutic...